January 24, 2023
Meet us at Probiota 2023! 24 January 2023 – 2 min read We’re excited to announce our attendance at the IPA World Congress +
Clinical Evidence
Find all published clinical trials by therapeutic area and product of interest
i.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life
Lorenzo-Zúñiga V, et al · 2014
Combination of a probiotic and an antispasmodic increases quality of life and reduces symptoms in patients with irritable bowel syndrome: a pilot study
Barraza-Ortiz DA, et al · 2020
Efficacy of probiotic i3.1 symptomatic improvement in patients with lactose intolerance
Cano-Contreras A, et al · 2020
Comparative effect of the i3.1 probiotic formula in two animal models of colitis
Lorén V, et al · 2017
Derived postbiotics of a multi‐strain probiotic formula clinically validated for the treatment of Irritable Bowel Syndrome
Perez M, et al · 2020
Dedicated to microbiome science
Read updated information about the microbiota and its link with human health
Information intented for Business to Business purpose and health care professionals
December 20, 2022
A newly published clinical trial in Gut Microbes – a top journal reporting the latest science in microbiota – has confirmed that Kaneka Group
November 29, 2022
Meet us at Food ingredients Europe 29 November 2022 – 2 min read We are excited to be exhibiting for the first time at
November 22, 2022
To offer a preventive, natural solution to Filipinos in risk of high cholesterol, Pharex and AB-BIOTICS have recently launched Biome Lipidec.
October 17, 2022
We are excited to be attending not one but three events in Asia during the remainder of this year. As part of Kaneka Probiotics,
June 27, 2022
For World Microbiome Day, let’s talk about gut dysbiosis and its detrimental impact in human health.
